Variant report

Variant	nsv891958
Chromosome Location	chr9:208549-452926
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2555)
CpG islands
(count:549)
Chromatin interactive
region (count:162)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2555 , 50 per page) page: 1 2 3 4 5 6 7 ... 52

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:229136-229466	K562	blood:	n/a	n/a
2	ARID3A	chr9:371491-371553	K562	blood:	n/a	n/a
3	ARID3A	chr9:214214-215154	K562	blood:	n/a	n/a
4	ARID3A	chr9:267916-268404	K562	blood:	n/a	n/a
5	ARID3A	chr9:237608-238477	K562	blood:	n/a	n/a
6	ARID3A	chr9:260270-260544	K562	blood:	n/a	n/a
7	ARID3A	chr9:336046-336405	HepG2	liver:	n/a	n/a
8	ARID3A	chr9:210220-210873	K562	blood:	n/a	n/a
9	ARID3A	chr9:250210-251866	K562	blood:	n/a	n/a
10	ARID3A	chr9:215966-216247	K562	blood:	n/a	n/a
11	ARID3A	chr9:272095-272522	K562	blood:	n/a	n/a
12	ARID3A	chr9:238911-239096	K562	blood:	n/a	n/a
13	ARID3A	chr9:272758-273406	K562	blood:	n/a	chr9:273064-273079
14	ATF1	chr9:211078-211816	K562	blood:	n/a	n/a
15	ATF1	chr9:222266-222777	K562	blood:	n/a	n/a
16	ATF1	chr9:272781-273161	K562	blood:	n/a	n/a
17	ATF1	chr9:270753-271026	K562	blood:	n/a	n/a
18	ATF1	chr9:312958-313372	K562	blood:	n/a	n/a
19	ATF1	chr9:249153-249485	K562	blood:	n/a	n/a
20	ATF1	chr9:272150-272512	K562	blood:	n/a	n/a
21	ATF1	chr9:428430-428702	K562	blood:	n/a	n/a
22	ATF2	chr9:297286-297859	GM12878	blood:	n/a	n/a
23	ATF2	chr9:272677-273240	GM12878	blood:	n/a	n/a
24	ATF2	chr9:272650-273286	GM12878	blood:	n/a	n/a
25	ATF3	chr9:210212-210461	K562	blood:	n/a	n/a
26	ATF3	chr9:272081-272576	K562	blood:	n/a	n/a
27	ATF3	chr9:326568-327022	H1-hESC	embryonic stem cell:	n/a	n/a
28	BACH1	chr9:214677-214706	H1-hESC	embryonic stem cell:	n/a	n/a
29	BACH1	chr9:450112-450344	H1-hESC	embryonic stem cell:	n/a	n/a
30	BACH1	chr9:214910-215270	H1-hESC	embryonic stem cell:	n/a	n/a
31	BATF	chr9:278668-278987	GM12878	blood:	n/a	n/a
32	BATF	chr9:297422-297902	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
33	BATF	chr9:297420-297885	GM12878	blood:	n/a	chr9:297684-297695 chr9:297685-297695
34	BCL11A	chr9:331212-331567	H1-hESC	embryonic stem cell:	n/a	n/a
35	BCLAF1	chr9:214465-215559	GM12878	blood:	n/a	n/a
36	BCLAF1	chr9:272677-273191	GM12878	blood:	n/a	chr9:272862-272871
37	BCLAF1	chr9:297419-297950	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
38	BCLAF1	chr9:307023-307293	GM12878	blood:	n/a	n/a
39	BCLAF1	chr9:297343-297922	GM12878	blood:	n/a	chr9:297687-297696 chr9:297688-297697
40	BCLAF1	chr9:272658-273387	GM12878	blood:	n/a	chr9:272862-272871
41	BHLHE40	chr9:218973-219054	K562	blood:	n/a	n/a
42	BHLHE40	chr9:211108-211404	K562	blood:	n/a	n/a
43	BHLHE40	chr9:270725-270976	GM12878	blood:	n/a	n/a
44	BHLHE40	chr9:215354-215372	GM12878	blood:	n/a	n/a
45	BHLHE40	chr9:214569-215152	GM12878	blood:	n/a	n/a
46	BHLHE40	chr9:214650-215428	K562	blood:	n/a	n/a
47	BHLHE40	chr9:272179-272510	K562	blood:	n/a	n/a
48	BHLHE40	chr9:259627-260475	K562	blood:	n/a	n/a
49	BHLHE40	chr9:209140-209345	K562	blood:	n/a	n/a
50	BHLHE40	chr9:297517-297717	K562	blood:	n/a	n/a

(count:549 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:213650-213700	AG04450	lung:	fetal
2	chr9:214612-214662	ECC-1	luminal epithelium:	n/a
3	chr9:211689-211739	Jurkat	blood:	n/a
4	chr9:426894-426944	HRPEpiC	eye:	n/a
5	chr9:211689-211739	AG09319	gingival:	n/a
6	chr9:214612-214662	IMR90	lung:	fetal
7	chr9:214268-214318	U87	brain:	n/a
8	chr9:215368-215418	HRE	kidney:	n/a
9	chr9:213650-213700	MCF10A-Er-Src	breast:	n/a
10	chr9:211689-211739	SK-N-SH	brain:	n/a
11	chr9:214690-214740	PrEC	prostate:	n/a
12	chr9:214268-214318	HEK293	kidney:	embryo
13	chr9:215368-215418	GM06990	blood:	n/a
14	chr9:214268-214318	HL-60	blood:	n/a
15	chr9:214612-214662	NH-A	brain:	n/a
16	chr9:214268-214318	GM19239	blood:	n/a
17	chr9:213650-213700	SK-N-MC	brain:	n/a
18	chr9:213650-213700	AG09319	gingival:	n/a
19	chr9:214690-214740	HCPEpiC	choroid plexus:	n/a
20	chr9:213650-213700	PrEC	prostate:	n/a
21	chr9:426894-426944	HEEpiC	esophagus:	n/a
22	chr9:273072-273122	HPAEpiC	pulmonary alveolar:	n/a
23	chr9:215368-215418	CMK	blood:	n/a
24	chr9:273072-273122	CMK	blood:	n/a
25	chr9:211689-211739	HRPEpiC	eye:	n/a
26	chr9:213650-213700	HRE	kidney:	n/a
27	chr9:211689-211739	AG09309	skin:	n/a
28	chr9:426894-426944	HRCEpiC	kidney:	n/a
29	chr9:214612-214662	MCF10A-Er-Src	breast:	n/a
30	chr9:213650-213700	IMR90	lung:	fetal
31	chr9:213650-213700	CMK	blood:	n/a
32	chr9:214268-214318	BE2_C	brain:	n/a
33	chr9:214268-214318	SK-N-MC	brain:	n/a
34	chr9:214268-214318	HMEC	breast:	n/a
35	chr9:214268-214318	IMR90	lung:	fetal
36	chr9:215561-215611	HCF	heart:	n/a
37	chr9:273072-273122	SKMC	muscle:	n/a
38	chr9:215561-215611	HEEpiC	esophagus:	n/a
39	chr9:214268-214318	RPTEC	kidney:	n/a
40	chr9:214690-214740	NT2-D1	testis:	n/a
41	chr9:215561-215611	GM19239	blood:	n/a
42	chr9:214690-214740	AG10803	skin:	n/a
43	chr9:273072-273122	K562	blood:	n/a
44	chr9:214690-214740	GM12891	blood:	n/a
45	chr9:215368-215418	IMR90	lung:	fetal
46	chr9:213650-213700	ECC-1	luminal epithelium:	n/a
47	chr9:214690-214740	HRCEpiC	kidney:	n/a
48	chr9:215368-215418	ProgFib	skin:	n/a
49	chr9:213650-213700	AG09309	skin:	n/a
50	chr9:211689-211739	SK-N-SH_RA	brain:	n/a

(count:162 , 50 per page) page: 1 2 3 4

No.	Distal block	Cell Line	Cell type
1	chr9:240408..242135-chr9:247395..249007,2	MCF-7	breast:
2	chr9:385494..386481-chr9:546680..547596,3	MCF-7	breast:
3	chr9:246962..249799-chr9:250077..252857,2	K562	blood:
4	chr9:213656..215329-chr9:262330..263868,2	K562	blood:
5	chr9:224171..226015-chr9:253370..255238,2	MCF-7	breast:
6	chr9:218197..221460-chr9:224650..228237,4	K562	blood:
7	chr9:213518..215162-chr9:305580..308186,2	K562	blood:
8	chr9:250806..252981-chr9:269858..272236,2	MCF-7	breast:
9	chr9:350965..353575-chr9:397923..399924,2	K562	blood:
10	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
11	chr9:217275..219531-chr9:301975..303827,2	MCF-7	breast:
12	chr9:213868..216890-chr9:248711..251891,4	K562	blood:
13	chr9:387700..389795-chr9:395557..397565,2	MCF-7	breast:
14	chr9:318530..320927-chr9:322721..325349,2	K562	blood:
15	chr9:276314..278461-chr9:285139..287718,2	K562	blood:
16	chr9:237820..240828-chr9:247584..251042,3	K562	blood:
17	chr9:326951..329483-chr9:330404..332162,2	K562	blood:
18	chr9:210056..211721-chr9:271493..274380,2	K562	blood:
19	chr9:211063..213249-chr9:216572..219831,3	K562	blood:
20	chr9:207715..211592-chr9:270281..275557,5	K562	blood:
21	chr1:27191066..27191830-chr9:408050..409042,2	NB4	blood:
22	chr9:396391..399763-chr9:403196..405645,3	K562	blood:
23	chr9:252242..255061-chr9:271559..273805,3	K562	blood:
24	chr9:270180..272736-chr9:272837..274435,2	K562	blood:
25	chr9:326951..329483-chr9:330404..332162,2	K562	blood:
26	chr9:414319..416465-chr9:419585..421155,2	MCF-7	breast:
27	chr9:396391..399763-chr9:403196..405645,3	K562	blood:
28	chr9:237104..239333-chr9:240417..242425,2	K562	blood:
29	chr9:331276..333871-chr9:335644..338943,3	MCF-7	breast:
30	chr9:224153..226474-chr9:270248..273178,2	K562	blood:
31	chr9:347478..348338-chr9:806313..807172,2	MCF-7	breast:
32	chr9:255761..258409-chr9:263285..266102,2	K562	blood:
33	chr9:223853..225771-chr9:261619..263535,2	K562	blood:
34	chr9:276287..280123-chr9:282139..284880,4	K562	blood:
35	chr9:444957..447415-chrX:145121393..145123151,2	MCF-7	breast:
36	chr9:396487..398165-chr9:401103..402938,2	K562	blood:
37	chr9:285389..289218-chr9:290727..294143,4	K562	blood:
38	chr9:211063..213249-chr9:216572..219831,3	K562	blood:
39	chr9:216842..219174-chr9:220888..224256,4	K562	blood:
40	chr9:438728..443718-chr9:444221..448963,4	K562	blood:
41	chr9:288365..290115-chr9:299185..301598,2	MCF-7	breast:
42	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
43	chr9:418287..419917-chr9:426635..429458,2	MCF-7	breast:
44	chr9:212468..215901-chr9:260350..263868,4	K562	blood:
45	chr9:223210..226112-chr9:277917..282090,3	K562	blood:
46	chr9:211912..213756-chr9:227781..229604,2	K562	blood:
47	chr9:261493..264345-chr9:269680..272564,2	MCF-7	breast:
48	chr9:265556..268525-chr9:268878..270498,2	K562	blood:
49	chr9:224171..226015-chr9:253370..255238,2	MCF-7	breast:
50	chr9:277861..283096-chr9:291676..296273,5	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-C9orf66-1	chr9:267966-268273	ENSG00000235880.1
2	lnc-C9orf66-1	chr9:272905-273002	ENSG00000235880.1

No data

Variant related genes	Relation type
DOCK8	TF binding region
ENSG00000235880	TF binding region
C9orf66	TF binding region
DOCK8	CpG island
ENSG00000235880	CpG island
C9orf66	CpG island
ENSG00000227155	chromatin interactions
ENSG00000101191	chromatin interactions
ENSG00000226403	chromatin interactions
ENSG00000235880	chromatin interactions
ENSG00000107099	chromatin interactions
ENSG00000183784	chromatin interactions

Extended variants
information (count: 13560 )
Associated
traits (count: 121 )

Variant overlapped rSNPs/rCNVs (count:13560 , 50 per page) page: 1 2 3 4 5 6 7 ... 272

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs644809	chr9:208549-208550	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs576973988	chr9:208551-208552	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs541146478	chr9:208613-208614	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs559733100	chr9:208627-208628	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs12351272	chr9:208635-208636	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs644383	chr9:208665-208666	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs141853114	chr9:208666-208667	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs537966755	chr9:208695-208696	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs530813097	chr9:208743-208744	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs558102303	chr9:208749-208750	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs540237576	chr9:208769-208770	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs191831484	chr9:208779-208780	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs528223508	chr9:208780-208781	Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs74761242	chr9:208880-208881	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs568121125	chr9:208917-208918	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs535109377	chr9:208921-208922	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs550511308	chr9:208938-208939	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs570055145	chr9:208954-208955	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs561565583	chr9:208961-208962	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs558756659	chr9:208962-208963	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs183131054	chr9:208998-208999	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs188186039	chr9:209006-209007	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs560649158	chr9:209013-209014	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs553193213	chr9:209020-209021	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs574833947	chr9:209045-209046	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs76642232	chr9:209046-209047	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs192517900	chr9:209094-209095	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs147101440	chr9:209103-209104	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs184447412	chr9:209134-209135	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs564337641	chr9:209146-209147	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs528295305	chr9:209150-209151	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs116562422	chr9:209151-209152	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs77425965	chr9:209171-209172	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs528973865	chr9:209222-209223	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs62533311	chr9:209231-209232	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs531922140	chr9:209245-209246	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs568493957	chr9:209252-209253	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs531145521	chr9:209262-209263	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs552468669	chr9:209288-209289	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs571075922	chr9:209290-209291	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs534912839	chr9:209291-209292	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs553519460	chr9:209294-209295	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs568505693	chr9:209323-209324	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs631411	chr9:209325-209326	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs116090497	chr9:209338-209339	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs114626614	chr9:209354-209355	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs473700	chr9:209359-209360	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs138545996	chr9:209370-209371	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs113467588	chr9:209372-209373	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs573052891	chr9:209384-209385	Enhancers Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:121)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	20164920	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Lynch syndrome	18415027	CNVD
Retinoblastoma	21504564	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	22286061	CNVD
Williams-beuren syndrome	18553513	CNVD
Disorders of sex development	21048976	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
prenatal diagnosis	20453657	CNVD
Gastric cancer	16715143	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Autism	22495311	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Schizophrenia	20967226	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Developmental delay	20808231	CNVD
Obesity	20808231	CNVD
Myelodysplastic syndrome	21251322	CNVD
Primary immunodeficiency	22942019	CNVD
Melanoma	20877625	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	21215367	CNVD
Renal cell carcinoma	21215367	CNVD
Williams Syndrome	20824207	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:3312 , 50 per page) page: 1 2 3 4 5 6 7 ... 67

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:206600-208800	Weak transcription	Primary neutrophils fromperipheralblood	blood
2	chr9:207800-213600	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr9:208000-208800	Enhancers	K562	blood
4	chr9:208400-208600	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr9:208600-209800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
6	chr9:208800-209800	Enhancers	Primary hematopoietic stem cells short term culture	blood
7	chr9:208800-209800	Flanking Active TSS	K562	blood
8	chr9:208800-213200	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr9:209200-209800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr9:209200-209800	Enhancers	Spleen	Spleen
11	chr9:209800-210400	Enhancers	Monocytes-CD14+_RO01746	blood
12	chr9:209800-211000	Weak transcription	Spleen	Spleen
13	chr9:209800-213400	Enhancers	K562	blood
14	chr9:209800-213600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
15	chr9:209800-214000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr9:210400-210600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
17	chr9:210600-211000	Enhancers	Monocytes-CD14+_RO01746	blood
18	chr9:210600-211400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
19	chr9:210800-212600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
20	chr9:211000-211400	Enhancers	Pancreas	Pancrea
21	chr9:211000-211400	Enhancers	Spleen	Spleen
22	chr9:211000-214600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
23	chr9:211200-211400	Enhancers	Placenta	Placenta
24	chr9:211200-212200	Enhancers	Adipose Nuclei	Adipose
25	chr9:211400-211600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
26	chr9:211400-212000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
27	chr9:211400-212200	Enhancers	Breast Myoepithelial Primary Cells	Breast
28	chr9:211400-213600	Weak transcription	Pancreas	Pancrea
29	chr9:211400-214000	Enhancers	Primary B cells from cord blood	blood
30	chr9:211400-214000	Weak transcription	Spleen	Spleen
31	chr9:211600-211800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
32	chr9:211800-212600	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
33	chr9:212000-214400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr9:212200-214000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
35	chr9:212200-214000	Weak transcription	Adipose Nuclei	Adipose
36	chr9:212400-213000	Enhancers	Primary hematopoietic stem cells	blood
37	chr9:212600-212800	Bivalent/Poised TSS	Fetal Kidney	kidney
38	chr9:212600-212800	Enhancers	Skeletal Muscle Female	skeletal muscle
39	chr9:212600-213000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
40	chr9:212600-213600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
41	chr9:213000-214000	Weak transcription	Primary hematopoietic stem cells	blood
42	chr9:213000-215200	Active TSS	Brain Substantia Nigra	brain
43	chr9:213200-213400	Bivalent/Poised TSS	Fetal Kidney	kidney
44	chr9:213200-214400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
45	chr9:213400-213800	Flanking Active TSS	K562	blood
46	chr9:213400-214600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr9:213600-214000	Enhancers	Primary B cells from peripheral blood	blood
48	chr9:213600-214000	Enhancers	Placenta	Placenta
49	chr9:213600-214200	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr9:213600-214200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links